Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Giallongo

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Minerva Pediatrics|September 13, 2021
Early intra-articular corticosteroid injection is predictors of remission of juvenile idiopathic arthritisFederica Filosco, Alessandro Giallongo, Salvatore Leonardi, et al.
Journal of Clinical Medicine|August 12, 2022
Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old DiseaseSara Manti, Alessandro Giallongo, Maria Papale, et al.
Italian Journal of Pediatrics|September 11, 2022
Pathogenesis, diagnosis, dietary management, and prevention of gastrointestinal disorders in the paediatric populationGiulio Pulvirenti, Vincenzo Sortino, Sara Manti, et al.
Acta Neurologica Belgica|June 12, 2020
Clinicoradiographic data and management of children with Chiari malformation type 1 and 1.5: an Italian case seriesAlessandro Giallongo, Piero Pavone, Stefania Piera Tomarchio, et al.
Pediatrics and Neonatology|December 29, 2024
Near-infrared spectroscopy (NIRS) as a tool to prevent cerebral desaturation in newborns with bradycardia events: A systematic reviewRaffaele Falsaperla, Guido Leone, Alessandro Giallongo, et al.
Pediatric Pulmonology|November 28, 2023
Combining biologics and CFTR modulators is safe: A pilot, observational, monocenter studySara Manti, Alessandro Giallongo, Giuseppe Fabio Parisi, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|July 27, 2022
Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic reviewSara Manti, Alessandro Giallongo, Giuseppe Fabio Parisi, et al.
Drugs in Context|August 9, 2019
Novel therapeutic targets for allergic airway disease in childrenAlessandro Giallongo, Giuseppe Fabio Parisi, Amelia Licari, et al.
Children (Basel, Switzerland)|November 11, 2022
Impact of COVID-19 Pandemic and Lockdown on the Epidemiology of RSV-Mediated Bronchiolitis: Experience from Our CentreSara Manti, Alessandro Giallongo, Giuseppe Fabio Parisi, et al.
Pediatric Pulmonology|January 2, 2023
Safety of biologics in severe asthmatic patients with SARS-CoV-2 infection: A prospective studySara Manti, Alessandro Giallongo, Giulia Pecora, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Minerva Pediatrics|September 13, 2021
Early intra-articular corticosteroid injection is predictors of remission of juvenile idiopathic arthritisFederica Filosco, Alessandro Giallongo, Salvatore Leonardi, et al.
Journal of Clinical Medicine|August 12, 2022
Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old DiseaseSara Manti, Alessandro Giallongo, Maria Papale, et al.
Italian Journal of Pediatrics|September 11, 2022
Pathogenesis, diagnosis, dietary management, and prevention of gastrointestinal disorders in the paediatric populationGiulio Pulvirenti, Vincenzo Sortino, Sara Manti, et al.
Acta Neurologica Belgica|June 12, 2020
Clinicoradiographic data and management of children with Chiari malformation type 1 and 1.5: an Italian case seriesAlessandro Giallongo, Piero Pavone, Stefania Piera Tomarchio, et al.
Pediatrics and Neonatology|December 29, 2024
Near-infrared spectroscopy (NIRS) as a tool to prevent cerebral desaturation in newborns with bradycardia events: A systematic reviewRaffaele Falsaperla, Guido Leone, Alessandro Giallongo, et al.
Pediatric Pulmonology|November 28, 2023
Combining biologics and CFTR modulators is safe: A pilot, observational, monocenter studySara Manti, Alessandro Giallongo, Giuseppe Fabio Parisi, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|July 27, 2022
Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic reviewSara Manti, Alessandro Giallongo, Giuseppe Fabio Parisi, et al.
Drugs in Context|August 9, 2019
Novel therapeutic targets for allergic airway disease in childrenAlessandro Giallongo, Giuseppe Fabio Parisi, Amelia Licari, et al.
Children (Basel, Switzerland)|November 11, 2022
Impact of COVID-19 Pandemic and Lockdown on the Epidemiology of RSV-Mediated Bronchiolitis: Experience from Our CentreSara Manti, Alessandro Giallongo, Giuseppe Fabio Parisi, et al.
Pediatric Pulmonology|January 2, 2023
Safety of biologics in severe asthmatic patients with SARS-CoV-2 infection: A prospective studySara Manti, Alessandro Giallongo, Giulia Pecora, et al.
Pageof 2